Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ranbaxy Laboratories Ltd Announces Change Of Financial Year

Tuesday, 29 Oct 2013 07:07am EDT 

Ranbaxy Laboratories Ltd announced that the Board of Directors of the Company at its meeting held on October 29, 2013, inter alia, have approved Change of financial year of the Company from January-December to April-March effective April 01, 2014. In view of this, the current financial year will be for a period of 15 months i.e. January, 2013 to March, 2014.